DE HB319 | 2017-2018 | 149th General Assembly
Status
Completed Legislative Action
Spectrum: Moderate Partisan Bill (Democrat 15-2)
Status: Passed on June 13 2018 - 100% progression
Action: 2018-06-13 - Signed by Governor
Text: Latest bill text (Engrossed) [HTML]
Spectrum: Moderate Partisan Bill (Democrat 15-2)
Status: Passed on June 13 2018 - 100% progression
Action: 2018-06-13 - Signed by Governor
Text: Latest bill text (Engrossed) [HTML]
Summary
This legislation creates a benchmark for determining when a treatment or service is no longer experimental or investigational. When Medicare determines that a treatment is safe for its population, commercial insurers in Delaware may no longer deny coverage on that basis. This bill will remove inconsistencies for properly-evidenced treatments between payers.
Title
An Act To Amend Title 18 Of The Delaware Code Relating To Experimental Treatment Health Insurance Coverage.
Sponsors
Roll Calls
2018-05-10 - Senate - Senate Third Reading (Y: 20 N: 0 NV: 0 Abs: 1) [PASS]
2018-04-24 - House - House Third Reading (Y: 41 N: 0 NV: 0 Abs: 0) [PASS]
2018-04-24 - House - House Third Reading (Y: 41 N: 0 NV: 0 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2018-06-13 | Signed by Governor | |
| 2018-05-10 | Passed By Senate. Votes: 20 YES 1 ABSENT | |
| 2018-05-02 | Reported Out of Committee (Banking, Business & Insurance) in Senate with 1 Favorable, 3 On Its Merits | |
| 2018-04-25 | Assigned to Banking, Business & Insurance Committee in Senate | |
| 2018-04-24 | Passed By House. Votes: 41 YES | |
| 2018-04-24 | Amendment HA 1 to HS 1 - Passed In House by Voice Vote | |
| 2018-04-18 | Reported Out of Committee (Economic Development/Banking/Insurance/Commerce) in House with 7 On Its Merits | |
| 2018-04-17 | Amendment HA 1 to HS 1 - Introduced and Placed With Bill | |
| 2018-04-12 | Assigned to Economic Development/Banking/Insurance/Commerce Committee in House | |
| 2018-04-12 | was introduced and adopted in lieu of HB 319 |
